LCTX icon

Lineage Cell Therapeutics

107 hedge funds and large institutions have $113M invested in Lineage Cell Therapeutics in 2018 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 33 increasing their positions, 21 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

less funds holding

Funds holding:

25% less capital invested

Capital invested by funds: $152M → $113M (-$38.5M)

34% less call options, than puts

Call options by funds: $109K | Put options by funds: $164K

47% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 17

Holders
107
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$109K
Puts
$164K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
76
$24K
77
$24K
78
$23K
79
$21K
80
$21K
81
$21K
82
$21K
83
$21K
84
$14K
85
$13K
86
$12K
87
$11.7K
88
$11K
89
$10K
90
$10K
91
$10K
92
$8K
93
$7.08K
94
$7K
95
$6.18K
96
$4K
97
$3K
98
$3K
99
$2K
100
$2K